InvestorsHub Logo
Followers 22
Posts 4084
Boards Moderated 0
Alias Born 04/29/2016

Re: None

Thursday, 05/11/2017 3:39:47 PM

Thursday, May 11, 2017 3:39:47 PM

Post# of 3898
This is only 30% of the run that is yet to come. 5 catalysts between now and 2Q 2018...4 in 2017...lots of sustainable cash. 15 to 20 dollar target. Buying below 4 is an absolute steal! This is also a very viable BO company. Big pharma is anemic in R@D and is on the prowl for promising and advancing smaller bio techs!